45 results on '"Van Meerbeeck, Jan P."'
Search Results
2. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
3. DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis
4. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)
5. Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood
6. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review
7. Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based study
8. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
9. Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial
10. Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study
11. Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies
12. Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study
13. The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
14. What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
15. Mesothelioma treatment: Are we on target? A review
16. Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
17. Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials
18. The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?
19. Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption
20. Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
21. The Effect of Clinical Covariates on the Diagnostic and Prognostic Value of Soluble Mesothelin and Megakaryocyte Potentiating Factor
22. A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
23. European guidelines for the management of malignant pleural mesothelioma
24. Malignant pleural mesothelioma: The standard of care and challenges for future management
25. Small-cell lung cancer
26. Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675)
27. Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?
28. Endoscopic and Endobronchial Ultrasonography According to the Proposed Lymph Node Map Definition in the Seventh Edition of the Tumor, Node, Metastasis Classification for Lung Cancer
29. EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes—an International Multi-Centre Experience
30. Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
31. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy
32. The Yield of Endoscopic Ultrasound in Lung Cancer Staging: Does Lymph Node Size Matter?
33. Systemic Therapy of Bronchioloalveolar Carcinoma: Results of the First IASLC/ASCO Consensus Conference on Bronchioloalveolar Carcinoma
34. Esophageal Endoscopic Ultrasound With Fine-Needle Aspiration With an On-site Cytopathologist: High Accuracy for the Diagnosis of Mediastinal Lymphadenopathy
35. Novel teatment options in early-stage non-small-cell lung cancer
36. Hypofractionated external beam radiotherapy as retreatment for symptomatic non–small-cell lung carcinoma: an effective treatment?
37. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy
38. Lung Cancer in Belgium
39. Small-cell lung cancer: local therapy for a systemic disease?
40. Neoadjuvant chemotherapy in early stage non-small cell lung cancer
41. Optimal approach for upfront resectable non-small-cell lung cancer
42. Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature
43. The controversial role of surgery in stage III NSCLC
44. Reply: Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer
45. Short Report from the European Society of Medical Oncology: Oral Abstracts on Mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.